Stada Grows In Russia And CIS With Takeda Brands
Executive Summary
Stada will pay $660m for a basket of 20 brands from Takeda to expand its consumer health portfolio in Russia and a number of strategically important CIS markets.
You may also be interested in...
Stada Makes US Consumer Health Play After Strong Gains In Europe
Stada has entered the US dietary supplements category following significant gains for its Branded Products business in 2020. Acquisitions helped to drive up Branded Products sales by 27% last year, enabling Stada to become a top-five player in Europe's consumer health market.
Stada UK Head On COVID-19 Impact, Local Growth Strategy And OTC Brand Innovation
Exclusive: HBW Insight talks to Stada executive vice-president Roger Scarlett-Smith on the progress of the company's ambitious growth strategy, the impact of the coronavirus and its new innovation centre in Yorkshire, England.
Stada Takes Lead In Russia's OTC Market As Group Sales Rise Double-Digits
Stada has taken the lead in the Russian OTC market and is implementing a turnaround plan in the country to take the business to the next level.